Martin Johansson holds a doctorate in organic chemistry from Lund University, Sweden, where he is currently an Associate Professor at the Center for Analysis and Synthesis. He has almost 20 years’ experience of medicinal chemistry and commercial drug discovery. Martin has previously held positions as senior researcher in AstraZeneca’s organization for Discovery R&D, in Södertälje, […]
http://aqilion.com/wp-content/uploads/2019/03/aqilion_logo_main.png00Aqilionhttp://aqilion.com/wp-content/uploads/2019/03/aqilion_logo_main.pngAqilion2019-08-22 08:01:412019-09-11 09:39:34Aqilion hires Martin Johansson as medicinal chemistry expert
In March of 2018, AQILION AB (formerly Partners för Utvecklingsinvesteringar inom Life Sciences, P.U.L.S. AB) carried out a directed issue of “units.” Each unit consisted of one (1) share and two (2) warrants. At that time, Aqilion raised SEK 100 million through subscription for shares. All outstanding warrants have now been converted to shares, which […]
http://aqilion.com/wp-content/uploads/2019/03/aqilion_logo_main.png00Aqilionhttp://aqilion.com/wp-content/uploads/2019/03/aqilion_logo_main.pngAqilion2019-07-18 08:01:222019-09-11 09:39:34Aqilion receives SEK 100 million through conversion of outstanding warrants
Aqilion searches for early innovative pharmaceutical projects thatare based on solid research resting on a firm biological foundation and offering both clinical relevance and patient benefit. Immunscape has developed innovative molecules that could potentially become new drugs for the treatment of cancer and autoimmune diseases. The project is currently in an early phase of development. […]
Sarah Fredriksson, our CEO, will present Aqilion at the NLS Days 11 – 12 of September. We are looking forward to seeing you during the partnering event. Read more about NLS days:https://www.nlsdays.com
We believe the best source of new treatments comes from identifying, shaping and strengthening early drug innovation. We seek ideas that could potentially both improve patient quality of life and streamline health care.
We want to challenge and apply science in combination with creativity and entrepreneurship to maximize health care value for society.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
Essential Website Cookies
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to deliver the website, you cannot refuse them without impacting how our site functions. You can block or delete them by changing your browser settings and force blocking all cookies on this website.
Other external services
We also use different external services like Google Webfonts, Google Maps and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Vimeo and Youtube video embeds: